Your browser doesn't support javascript.
loading
Accounting for EGFR Mutations in Epidemiologic Analyses of Non-Small Cell Lung Cancers: Examples Based on the International Lung Cancer Consortium Data.
Schmid, Sabine; Jiang, Mei; Brown, M Catherine; Fares, Aline; Garcia, Miguel; Soriano, Joelle; Dong, Mei; Thomas, Sera; Kohno, Takashi; Leal, Leticia Ferro; Diao, Nancy; Xie, Juntao; Wang, Zhichao; Zaridze, David; Holcatova, Ivana; Lissowska, Jolanta; Swiatkowska, Beata; Mates, Dana; Savic, Milan; Wenzlaff, Angela S; Harris, Curtis C; Caporaso, Neil E; Ma, Hongxia; Fernandez-Tardon, Guillermo; Barnett, Matthew J; Goodman, Gary; Davies, Michael P A; Pérez-Ríos, Mónica; Taylor, Fiona; Duell, Eric J; Schoettker, Ben; Brenner, Hermann; Andrew, Angeline; Cox, Angela; Ruano-Ravina, Alberto; Field, John K; Marchand, Loic Le; Wang, Ying; Chen, Chu; Tardon, Adonina; Shete, Sanjay; Schabath, Matthew B; Shen, Hongbing; Landi, Maria Teresa; Ryan, Brid M; Schwartz, Ann G; Qi, Lihong; Sakoda, Lori C; Brennan, Paul; Yang, Ping.
Afiliación
  • Schmid S; The Princess Margaret Cancer Centre and University Health Network, University of Toronto, Toronto, Ontario, Canada.
  • Jiang M; Department of Medical Oncology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.
  • Brown MC; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
  • Fares A; The Princess Margaret Cancer Centre and University Health Network, University of Toronto, Toronto, Ontario, Canada.
  • Garcia M; Division of Medical Oncology, Hospital de Base de São José do Rio Preto, SP, Brazil.
  • Soriano J; The Princess Margaret Cancer Centre and University Health Network, University of Toronto, Toronto, Ontario, Canada.
  • Dong M; The Princess Margaret Cancer Centre and University Health Network, University of Toronto, Toronto, Ontario, Canada.
  • Thomas S; University of Ottawa, Ottawa, Ontario, Canada.
  • Kohno T; The Princess Margaret Cancer Centre and University Health Network, University of Toronto, Toronto, Ontario, Canada.
  • Leal LF; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
  • Diao N; Lunenfeld-Tanenbaum Research Institute, Sinai Health Systems, Toronto, Ontario, Canada.
  • Xie J; Division of Genome Biology, National Cancer Centre Research Institute, Tokyo, Japan.
  • Wang Z; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil.
  • Zaridze D; Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Holcatova I; Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Lissowska J; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.
  • Swiatkowska B; Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.
  • Mates D; Russian N.N. Blokhin Cancer Research Centre, Moscow, Russian Federation.
  • Savic M; Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Wenzlaff AS; Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Harris CC; The Nofer Institute of Occupational Medicine, Lodz, Poland.
  • Caporaso NE; National Institute of Public Health, Bucharest, Romania.
  • Ma H; Department of Thoracic Surgery, Clinical Center of Serbia, Belgrade, Serbia.
  • Fernandez-Tardon G; Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, Michigan.
  • Barnett MJ; Laboratory of Human Carcinogenesis, Centre for Cancer Research, National Institutes of Health, Bethesda, Maryland.
  • Goodman G; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Davies MPA; Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing, China.
  • Pérez-Ríos M; IUOPA, University of Oviedo, and ISPA (Health Research Institute of the Principality of Asturias) and CIBERESP, Asturias, Spain.
  • Taylor F; Program in Biostatistics Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Duell EJ; Swedish Cancer Institute, Seattle, Washington.
  • Schoettker B; Roy Castle Lung Cancer Research Programme, The University of Liverpool, Department of Molecular and Clinical Cancer Medicine, Liverpool, United Kingdom.
  • Brenner H; Department of Preventive Medicine and Public Health, University of Santiago de Compostela, Galicia, Spain.
  • Andrew A; CIBER de Epidemiología y Salud Pública, CIBERESP, Santiago de Compostela, Galicia, Spain.
  • Cox A; Department of Oncology and Metabolism, University of Sheffield Medical School, Sheffield, United Kingdom.
  • Ruano-Ravina A; Sheffield Teaching Hospitals Foundation Trust, Sheffield, United Kingdom.
  • Field JK; Catalan Institute of Oncology (ICO), Barcelona, Spain.
  • Marchand LL; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
  • Wang Y; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Chen C; Network of Aging Research, Heidelberg University, Heidelberg, Germany.
  • Tardon A; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Shete S; Network of Aging Research, Heidelberg University, Heidelberg, Germany.
  • Schabath MB; Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  • Shen H; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Landi MT; Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.
  • Ryan BM; Department of Oncology and Metabolism, University of Sheffield Medical School, Sheffield, United Kingdom.
  • Schwartz AG; Department of Preventive Medicine and Public Health, University of Santiago de Compostela, Galicia, Spain.
  • Qi L; CIBER de Epidemiología y Salud Pública, CIBERESP, Santiago de Compostela, Galicia, Spain.
  • Sakoda LC; Roy Castle Lung Cancer Research Programme, The University of Liverpool, Department of Molecular and Clinical Cancer Medicine, Liverpool, United Kingdom.
  • Brennan P; University of Hawaii Cancer Center, Honolulu, Hawaii.
  • Yang P; American Cancer Society, Atlanta, Georgia.
Cancer Epidemiol Biomarkers Prev ; 31(3): 679-687, 2022 Mar 01.
Article en En | MEDLINE | ID: mdl-35027437
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Cancer Epidemiol Biomarkers Prev Asunto de la revista: BIOQUIMICA / EPIDEMIOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Cancer Epidemiol Biomarkers Prev Asunto de la revista: BIOQUIMICA / EPIDEMIOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Estados Unidos